rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

SANUWAVE Health, Inc.

SNWV · Nasdaq

Health CareMedical DevicesNot moving yet

SNWV stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 46 weeks. It is 54.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 46
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$13.8M
Officials’ trades on record
0
Institutions holding
50 (-10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$9.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months14
Buyers · sellers0 · 4
WhoDidSharesTraded
Opaleye Management Inc.10% ownersold10,081at $16.111 May 2026filed 4 May 2026
Opaleye Management Inc.10% ownersold500at $16.111 May 2026filed 4 May 2026
Opaleye Management Inc.10% ownersold24,000at $16.1530 Apr 2026filed 4 May 2026
Opaleye Management Inc.10% ownersold1,000at $16.1530 Apr 2026filed 4 May 2026
Opaleye Management Inc.10% ownersold23,360at $17.2529 Apr 2026filed 30 Apr 2026
Opaleye Management Inc.10% ownersold1,000at $17.2529 Apr 2026filed 30 Apr 2026
Opaleye Management Inc.10% ownersold43,788at $18.4728 Apr 2026filed 30 Apr 2026
Opaleye Management Inc.10% ownersold2,500at $18.4728 Apr 2026filed 30 Apr 2026
Opaleye Management Inc.10% ownersold202at $20.5021 Apr 2026filed 21 Apr 2026
Opaleye Management Inc.10% ownersold11,267at $20.4617 Apr 2026filed 21 Apr 2026
Opaleye Management Inc.10% ownersold5,000at $20.4617 Apr 2026filed 21 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders50-10 on the quarter
New · exited15 · 25
Reported value$32.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Solas Capital Management, LLCadded · filed 14 Aug 2026610,968$6.1M+323,454+112.5%
AWM Investment Company, Inc.unchanged · filed 14 Aug 2026454,550$4.5M00.0%
Praetorian PR LLCadded · filed 14 Aug 2026395,000$4.0M+45,000+12.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026352,756$3.5M+3,882+1.1%
Opaleye Management Inc.reduced · filed 14 Aug 2026306,140$3.1M-675,127−68.8%
UBS Group AGadded · filed 13 Aug 2026256,791$2.6M+46,528+22.1%
BlackRock, Inc.reduced · filed 7 Aug 2026159,867$1.6M-321,673−66.8%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202686,098$861K-85,700−49.9%
CITADEL ADVISORS LLCadded · filed 14 Aug 202659,473$595K+41,375+228.6%
VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 202643,097$431K-6,184−12.5%
31 Dec 2024 – 30 Jun 2026
33158Dec 24Jun 25Sep 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Gregory Matthew Bazar Company insiderDirector · last 30 Sep 20260 · 0
Ian D. Miller Company insiderDirector · last 30 Sep 20260 · 0
James Tyler Company insiderDirector · last 30 Sep 20260 · 0
Jeffrey Blizard Company insiderDirector · last 30 Sep 20260 · 0
Morgan C. Frank Company insiderChief Executive Officer · last 30 Sep 20260 · 0
Opaleye Management Inc. Company insider10% owner · last 1 May 20265 · 6
David Timothy Wern Company insiderExec VP of Sales · last 30 Jan 20260 · 0
Manchester Management Pr, Llc Company insiderOther · last 12 Dec 20250 · 2
James E. Besser Company insiderOther · last 10 Dec 20250 · 3
Manchester Management Co Llc Company insiderOther · last 10 Dec 20251 · 3
Peter Stegagno Company insiderChief Operating Officer · last 5 Jun 20250 · 1
Iulian Cioanta Company insiderChief Sci. and Tech. Officer · last 15 May 20250 · 1

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202577.1%
Operating profit marginFY 2025 · to 31 Dec 202511.2%
Free cash flow marginFY 2025 · to 31 Dec 20254.4%
Return on capital employedFY 2025 · to 31 Dec 202525.4%
Cash conversionFY 2025 · to 31 Dec 202532.8%
Debt to equityFY 2025 · to 31 Dec 202517.07×
Interest coverFY 2025 · to 30 Sep 20250.16×
Research spendFY 2025 · to 31 Dec 20253.1%
Revenue growthFY 2025 · to 31 Dec 202543.7%
Earnings per share growthFY 2025 · to 31 Dec 202595.2%
Share count trendFY 2025 · to 24 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$12.0M

Analyst forecasts

No analyst forecasts yet.